Cationic liposomes containing mycobacterial lipids: a new powerful Th1 adjuvant system

被引:77
作者
Rosenkrands, I [1 ]
Agger, EM [1 ]
Olsen, AW [1 ]
Korsholm, KS [1 ]
Andersen, CS [1 ]
Jensen, KT [1 ]
Andersen, P [1 ]
机构
[1] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark
关键词
D O I
10.1128/IAI.73.9.5817-5826.2005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The immunostimulation provided by the mycobacterial cell wall has been exploited for many decades, e.g., in Freund's complete adjuvant. Recently, the underlying mechanism behind this adjuvant activity, including Toll receptor signaling, has begun to be unraveled, confirming the potential of mycobacterial constituents to act as adjuvants. In this study, the immunostimulatory properties of a Mycobacterium bovis BCG lipid extract were tested for their adjuvant activity. Administration of the lipids in dimethyl dioctadecyl ammonium bromide-based cationic liposomes induced a powerful Th1 response characterized by markedly elevated antigen-specific immunoglobulin G2a (IgG2a) isotype antibodies and substantial production of gamma interferon. The adjuvant formulation (designated mycosomes) elicited high levels of gamma interferon both in C57BL/6 as well as in Th2-prone BALB/c mice. Furthermore, the mycosomes induced immune responses to protein antigens from several sources including Mycobacterium tuberculosis, Chlamydia muridarum, and tetanus toxoid. In a tuberculosis challenge model, the mycosomes combined with the Ag85B-ESAT-6 fusion protein were demonstrated to have a unique ability to maintain sustained immunological memory at a level superior to live BCG.
引用
收藏
页码:5817 / 5826
页数:10
相关论文
共 43 条
[1]   T-CELL PROLIFERATIVE RESPONSE TO ANTIGENS SECRETED BY MYCOBACTERIUM-TUBERCULOSIS [J].
ANDERSEN, P ;
ASKGAARD, D ;
LJUNGQVIST, L ;
BENTZON, MW ;
HERON, I .
INFECTION AND IMMUNITY, 1991, 59 (04) :1558-1563
[3]   PROTEINS RELEASED FROM MYCOBACTERIUM-TUBERCULOSIS DURING GROWTH [J].
ANDERSEN, P ;
ASKGAARD, D ;
LJUNGQVIST, L ;
BENNEDSEN, J ;
HERON, I .
INFECTION AND IMMUNITY, 1991, 59 (06) :1905-1910
[4]   Development of immunoadjuvants for immunotherapy of cancer [J].
Azuma, I ;
Seya, T .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2001, 1 (07) :1249-1259
[5]   Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents [J].
Baldridge, JR ;
McGowan, P ;
Evans, JT ;
Cluff, C ;
Mossman, S ;
Johnson, D ;
Persing, D .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (07) :1129-1138
[6]   Immunostimulatory activity of aminoalkyl glucosaminide 4-phosphates (AGPs): induction of protective innate immune responses by RC-524 and RC-529 [J].
Baldridge, JR ;
Cluff, CW ;
Evans, JT ;
Lacy, MJ ;
Stephens, JR ;
Brookshire, VG ;
Wang, R ;
Ward, JR ;
Yorgensen, YM ;
Persing, DH ;
Johnson, DA .
JOURNAL OF ENDOTOXIN RESEARCH, 2002, 8 (06) :453-458
[7]   BCG AND CANCER .2. [J].
BAST, RC ;
ZBAR, B ;
BORSOS, T ;
RAPP, HJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 290 (26) :1458-1469
[8]   Mycobacterium bovis BCG cell wall-specific differentially expressed genes identified by differential display and cDNA subtraction in human macrophages [J].
Begum, NA ;
Ishii, K ;
Kurita-Taniguchi, M ;
Tanabe, M ;
Kobayashi, M ;
Moriwaki, Y ;
Matsumoto, M ;
Fukumori, Y ;
Azuma, I ;
Toyoshima, K ;
Seya, T .
INFECTION AND IMMUNITY, 2004, 72 (02) :937-948
[9]   IMPROVED SILVER STAINING OF PLANT-PROTEINS, RNA AND DNA IN POLYACRYLAMIDE GELS [J].
BLUM, H ;
BEIER, H ;
GROSS, HJ .
ELECTROPHORESIS, 1987, 8 (02) :93-99
[10]   ESAT-6 subunit vaccination against Mycobacterium tuberculosis [J].
Brandt, L ;
Elhay, M ;
Rosenkrands, I ;
Lindblad, EB ;
Andersen, P .
INFECTION AND IMMUNITY, 2000, 68 (02) :791-795